ExodusPoint Capital Management, LP

Position in IBRX — ImmunityBio, Inc.

CIK 1736225 NEW YORK, NY

Position in IBRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,692,691

+$1,046,041 QoQ

Shares Held

193,340

+129.3% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#78

of 403 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. IBRX ranks #44 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,692,691	193,340	+129.3%	Shares	Sole	2026-08-14
2026-03-31	$646,650	84,309	-77.1%	Shares	Sole	2026-05-14
2025-12-31	$728,404	367,881	+126.6%	Shares	Sole	2026-02-17
2025-09-30	$399,462	162,383	+20.3%	Shares	Sole	2025-11-14
2024-09-30	$502,307	135,029	+473.2%	Shares	Sole	2024-11-12
2023-12-31	$118,261	23,558	+129.6%	Shares	Sole	2024-02-14
2023-03-31	$18,676	10,262	-70.9%	Shares	Sole	2023-05-11
2021-03-31	$838,306	35,312	—	Shares	Other	2021-05-17
2020-09-30 NK	—	11,892	-87.8%	Shares	Sole	2020-11-16
2020-06-30 NK	—	97,471	+19.4%	Shares	Sole	2020-08-14
2020-03-31 NK	—	81,621	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.